Chemotherapy before surgery for colon cancer may improve survival, study shows

BMJ 2012; 345 doi: http://dx.doi.org/10.1136/bmj.e7487 (Published 6 November 2012)
Cite this as: BMJ 2012;345:e7487

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Susan Mayor
  1. 1London

Chemotherapy before surgery for locally advanced colon cancer significantly shrinks tumours, making them easier to remove and potentially reducing the risk of recurrence, shows a pilot study.1

Treating patients with other cancers of the digestive system with chemotherapy for several weeks before surgery is already standard practice, after trials showed that this prolonged survival. But the strategy had been considered too risky for colon cancer, because if tumour cells failed to respond and continued growing this could cause a potentially fatal blockage of the colon. It has also been difficult to determine which patients might benefit from preoperative chemotherapy.

The UK researchers randomly assigned 150 patients with locally advanced colorectal tumours to preoperative chemotherapy with three cycles of oxaliplatin, l-folinic acid, and fluorouracil …

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Article access

Article access for 1 day

Purchase this article for £20 $30 €32*

The PDF version can be downloaded as your personal record

* Prices do not include VAT

THIS WEEK'S POLL